Skip to content

The Effect of a Mindfulness-Based Stress Reduction Program on Premenstrual Symptoms: A Randomized Controlled Trial.

Nurdilan Şener Çetin, Ayça Şolt Kırca

Journal of midwifery & women's health 2023 DOI: 10.1111/jmwh.13530 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial Peer reviewed
Sample size 90
Population University women aged 20-30 who scored at least 45 on the Premenstrual Syndrome Scale and were not receiving other treatments for PMS
Intervention Mindfulness-based stress reduction (MBSR)
Duration 8 weekly 2.5-hour sessions plus a 6-hour silence retreat during week 6; outcomes assessed at baseline and immediately postintervention
Measures Premenstrual Syndrome Scale (PMSS)
Topics Meditation
Keywords Midwife Nurse Premenstrual syndrome
Registration NCT05191108
Key findings Women who received the 8-week MBSR program had significantly lower premenstrual symptom scores than controls immediately after the intervention (PMSS total 96.35 vs 123.02), with a large effect size (partial eta-squared 0.510) and significant reductions on all PMSS subscales. The authors conclude MBSR was effective in reducing premenstrual symptoms and may be used as a therapy for PMS.

Abstract

Premenstrual syndrome (PMS) is an important health problem that affects women of childbearing age. Mindfulness, a meditation practice that cultivates the acceptance of events as they occur in the moment without judgment, is a promising strategy to help women cope with PMS. This study aimed to test the efficacy of a mindfulness-based stress reduction (MBSR) program in decreasing premenstrual symptoms compared with a control group. This study was a prospective, single-masked randomized controlled trial conducted between February and April 2022 with 90 university students. Participants were women between 20 and 30 years of age, scored at least 45 on the Premenstrual Syndrome Scale (PMSS), and were not receiving other treatments for PMS. Participants were randomized into experimental (MBSR) and control groups in a 1:1 allocation. MBSR was provided in 8 weekly sessions lasting 2.5 hours and a 6-hour silence retreat during week 6. Symptoms of PMS were evaluated with the PMSS at baseline and postintervention. Differences between groups were compared postintervention using analysis of covariance to correct for baseline scores. The study was registered at www. gov before the data collection process was initiated (NCT05191108). Of the 90 enrolled participants, 74 participants completed the study and postintervention assessment (37 in each group). Immediately postintervention, the women in the experimental group had significantly lower PMS symptoms than women in the control group (PMSS total score, 96.35 vs 123.02; P < .001). The effect size for the change in premenstrual symptoms was large (partial η2 , 0.510). Specific symptoms measured by the PMSS subscales all showed significant reductions in scores in the MBSR group compared with the control group. A mindfulness stress reduction program was effective in reducing premenstrual symptoms. MBSR programs may be used as a therapy for PMS. Future studies should test MBSR in larger and more diverse groups of women with PMS.

Comparable studies

Other randomized controlled trials on meditation, most cited first.

Study Year Design Participants
Alterations in Brain and Immune Function Produced by Mindfulness Meditation Healthy employees in a work environment 2003 Randomized controlled trial n = 41
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Open hearts build lives: Positive emotions, induced through loving-kindness meditation, build consequential personal resources. Working adults 2008 Randomized controlled trial n = 139
Short-term meditation training improves attention and self-regulation Undergraduate Chinese students 2007 Randomized controlled trial n = 40
Mindfulness-Based Cognitive Therapy for Depression: Replication and Exploration of Differential Relapse Prevention Effects. Recovered recurrently depressed patients 2004 Randomized controlled trial n = 73

Explore topics